Philadelphia Trust CO Fibrogen Inc Transaction History

Philadelphia Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$18.57 - $35.68 $4.05 Million - $7.79 Million	-218,275 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$31.0 - $55.72 $296,825 - $533,519	9,575 Added 4.59%	218,275 $7.58 Million
Q4 2020 Feb 08, 2021	BUY	$37.09 - $48.97 $6.98 Million - $9.22 Million	188,300 Added 923.04%	208,700 $7.74 Million
Q3 2020 Nov 12, 2020	BUY	$40.47 - $45.5 $825,588 - $928,200	20,400 New	20,400 $839,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Philadelphia Trust CO, based on Form 13F filings with the SEC.

Stay updated on Philadelphia Trust CO with notifications on news.